SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
13-D SC 13D/A 11/5/2018
10-Q 10-Q 10/30/2018 9/30/2018
8-K 8-K 10/29/2018 10/29/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Results of Operations and Financial Condition; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 10/10/2018 10/9/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Entry into a Material Definitive Agreement; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 10/4/2018 10/3/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K 8-K 10/3/2018 9/27/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Financial Statements and Exhibits.
13-D SC 13G/A 9/10/2018
8-K 8-K 8/29/2018 8/29/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Regulation FD Disclosure and Financial Statements and Exhibits.
10-Q 10-Q 8/1/2018 6/30/2018
8-K 8-K 7/31/2018 7/31/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Results of Operations and Financial Condition; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 7/31/2018 7/31/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K 8-K 7/2/2018 6/29/2018
Abstract: 8-K filed by Amedisys, Inc. (AMED) covering Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 6/12/2018 6/6/2018
Abstract: 8-K filed by Amedisys, Inc. (AMED) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Submission of Matters to a Vote of Security Holder; and Financial Statements and Exhibits.
13-D SC 13D/A 6/6/2018
Registration Statement S-8 6/6/2018
8-K 8-K 6/4/2018 6/4/2018
Abstract: 8-K filed by Amedisys, Inc. (AMED) covering Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 5/24/2018 5/18/2018
Abstract: 8-K filed by Amedisys, Inc. (AMED) covering Entry into a Material Definitive Agreement.
10-Q 10-Q 5/8/2018 3/31/2018
8-K 8-K 5/7/2018 5/7/2018
Abstract: 8-K filed by Amedisys, Inc. (AMED) covering Results of Operations and Financial Condition; Regulation FD Disclosure; and Financial Statements and Exhibits.
Proxy DEF 14A 4/25/2018 6/6/2018

Displaying 1 to 20 (of 314 filings)

Contact Information

Amedisys Corporate Headquarters
3854 American Way
Baton Rouge, LA 70816
(225) 292-2031
Amedisys Executive Office
209 10th Avenue S.
Suite 512
Nashville, TN 37203
Request Information
^
To Top